Page 87 - 《中国药房》2024年24期
P. 87

基于单核苷酸多态性的阿片类镇痛药个体化用药研究
                                                                                            Δ


                 1*
          彭婷婷 ,朱效涛 ,宋琳琳 ,刘 健 ,郑 磊 ,杨 静                      2, 3, 4 # (1. 山东中医药大学第二附属医院药学部,济南
                                   2
                                                   3
                          2
                                           1
          250002;2.山东医学高等专科学校药学系,济南 250002;3.山东省立第三医院药学部,济南 250031;4.中国海
          洋大学医药学院,山东 青岛 266000)
          中图分类号  R971      文献标志码  A      文章编号  1001-0408(2024)24-3041-05
          DOI  10.6039/j.issn.1001-0408.2024.24.13

          摘  要  目的  探讨基因多态性与阿片类镇痛药的药物不良反应(ADR)及需求量的相关性,以期指导阿片类镇痛药的个体化用
          药。方法  利用已有循证医学证据确定阿片类镇痛药药效及ADR相关基因位点,选取强相关的单核苷酸多态性(SNP)位点开展
          临床病例对照研究。研究组分为ADR评价组与药物需求量评价组,其中ADR评价组共纳入254例癌痛患者,根据使用阿片类镇
          痛药后是否出现ADR分为试验亚组(出现ADR)和对照亚组(未出现ADR),两亚组分别纳入126例和128例患者;药物需求量评
          价组共纳入120例癌痛患者,根据使用阿片类镇痛药日剂量不同分为试验亚组(相当于口服吗啡日剂量≥100 mg)和对照亚组(相
          当于口服吗啡日剂量<100 mg),各纳入60例患者。对纳入研究的患者采用荧光原位杂交法进行SNP位点检测,采用SPSS 21.0
          软件和SNPStats工具对基因检测结果进行各亚组间比较和相关性分析,以评估所选SNP位点在临床真实病例中与阿片类镇痛药
          ADR 及药物需求量的相关性。结果  筛选出的强相关 SNP 位点有 CYP2D6*10(rs1065852,C>T)、CYP3A5*3(rs776746,A>G)、
          ABCB1(rs1045642,C>T)及 OPRM1(rs1799971,A>G)。基因检测结果显示,以上 SNP 位点等位基因分布频率均符合 Hardy-
          Weinberg遗传平衡。相关性分析结果显示,ADR评价组中,试验亚组与对照亚组比较,OPRM1(rs1799971,A>G)AA型占比更高
         (P<0.05);药物需求量评价组中,试验亚组与对照亚组比较,ABCB1(rs1045642,C>T)CC+CT 型占比更高(P<0.05)。结论
          OPRM1(rs1799971,A>G)AA 型与使用羟考酮后发生的 ADR 具有相关性;ABCB1(rs1045642,C>T)CC+CT 型患者的阿片类镇
          痛药需求量更高。
          关键词  阿片类镇痛药;单核苷酸多态性;基因多态性;个体化用药;药物不良反应;药物需求量


          Study on individualized use of opioid analgesics based on SNP polymorphism
                                                  2
                       1
                                     2
          PENG Tingting ,ZHU Xiaotao ,SONG Linlin ,LIU Jian ,ZHENG Lei ,YANG Jing   2, 3, 4 (1.  Dept.  of  Pharmacy,
                                                                        3
                                                            1
          the  Second Affiliated  Hospital  of  Shandong  University  of  Traditional  Chinese  Medicine,  Jinan  250002,  China;
          2.  Dept.  of  Pharmacy,  Shandong  Medical  College,  Jinan  250002,  China;3.  Dept.  of  Pharmacy,  Shandong
          Provincial  Third  Hospital,  Jinan  250031,  China;4.  School  of  Medical  and  Pharmaceutical  Science,  Ocean
          University of China, Shandong Qingdao 266000, China)
          ABSTRACT   OBJECTIVE  To  investigate  the  correlation  between  gene  polymorphisms  and  adverse  drug  reaction (ADR)  and
          demands  of  opioids,  aiming  to  guide  personalized  opioid  analgesic  therapy.  METHODS  The  existing  evidence-based  medical  data
          were adopted to identify gene loci related to the efficacy and ADR of opioid analgesics and select highly relevant single nucleotide
          polymorphism (SNP)  for  a  clinical  case-control  study. The  study  cohort  was  divided  into  two  evaluation  groups: ADR  assessment
          and  drug  demand  assessment.  The  ADR  assessment  group  included  254  cancer  pain  patients  and  was  subdivided  into  the  trial
          subgroup (with ADR) and the control subgroup (without ADR) based on the presence or absence of ADR following opioid usage;
          the  two  subgroups  included  126  and  128  patients,  respectively. The  drug  demand  assessment  group  included  a  total  of  120  cancer
          pain  patients,  who  were  divided  into  trial  subgroup (equivalent to  a  daily  dose  of  oral  morphine  ≥100  mg)  and  control  subgroup
         (equivalent to a daily dose of oral morphine <100 mg) based on the different daily doses of opioid analgesics, with 60 patients in
          each subgroup. Polymorphism detection of SNP loci in these patients was performed using fluorescence in situ hybridization. SPSS
          21.0  software  and  SNPStats  genetic  models  were  employed  to  compare  genetic  testing  results  between  subgroups  and  conduct
                                                             correlation  analyses,  aiming  to  evaluate  the  association  of  the
             Δ  基金项目 山 东 省 医 药 卫 生 科 技 发 展 计 划 项 目(No.       selected  SNP  loci  with  opioid  ADR  and  drug  demand  in
          202213010928);山 东 省 医 学 会 临 床 科 研 专 项 资 金 课 题(No.  clinical  real-world  cases.  RESULTS  The  strongly  correlated
          YXH2020ZX047);济南市科技计划(后补助)项目(No.202134016)         SNP  loci  identified  were  CYP2D6*10(rs1065852,C>T),
             *第一作者 主管药师,硕士。研究方向:临床药学。E-mail:
                                                             CYP3A5*3(rs776746,A>G),ABCB1(rs1045642,C>T)and
          zxyjh_lcyx@163.com
             # 通信作者 副主任药师,副教授,硕士生导师,博士。研究方向:                 OPRM1(rs1799971,A>G).  Genetic  testing  results  indicated
          临床药学。E-mail:15853199531@163.com                    that  the  allele  frequency  distributions  of  these  SNP  loci


          中国药房  2024年第35卷第24期                                              China Pharmacy  2024 Vol. 35  No. 24    · 3041 ·
   82   83   84   85   86   87   88   89   90   91   92